The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Montelukast Sodium Tablets Market Research Report 2025
Synopsis
Clinically used for the prevention and long-term treatment of asthma in adults and children
Global Montelukast Sodium Tablets market is projected to reach US$ 70080 million in 2029, increasing from US$ 35960 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Montelukast Sodium Tablets market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Montelukast Sodium Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Disha
Green Pine
Lunan
Tianyu Pharmaceutical
Otsuka Pharmaceutical
Unimark Remedies
Hanmi Fine Chemical
Qilu Pharmaceutical
Apocalypse Pharma
Amicogen
Hyey
Chem Partner
sinopharm
Curivo
Divine Savior
MSD
Pfizer
Segment by Type
4mg/Tablet
5mg/Tablet
Segment by Application
Adult
Child
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Montelukast Sodium Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Clinically used for the prevention and long-term treatment of asthma in adults and children
Global Montelukast Sodium Tablets market is projected to reach US$ 70080 million in 2029, increasing from US$ 35960 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Montelukast Sodium Tablets market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Montelukast Sodium Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Disha
Green Pine
Lunan
Tianyu Pharmaceutical
Otsuka Pharmaceutical
Unimark Remedies
Hanmi Fine Chemical
Qilu Pharmaceutical
Apocalypse Pharma
Amicogen
Hyey
Chem Partner
sinopharm
Curivo
Divine Savior
MSD
Pfizer
Segment by Type
4mg/Tablet
5mg/Tablet
Segment by Application
Adult
Child
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Montelukast Sodium Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Montelukast Sodium Tablets Market Overview
1.1 Product Overview and Scope of Montelukast Sodium Tablets
1.2 Montelukast Sodium Tablets Segment by Type
1.2.1 Global Montelukast Sodium Tablets Market Value Comparison by Type (2023-2029)
1.2.2 4mg/Tablet
1.2.3 5mg/Tablet
1.3 Montelukast Sodium Tablets Segment by Application
1.3.1 Global Montelukast Sodium Tablets Market Value by Application: (2023-2029)
1.3.2 Adult
1.3.3 Child
1.4 Global Montelukast Sodium Tablets Market Size Estimates and Forecasts
1.4.1 Global Montelukast Sodium Tablets Revenue 2018-2029
1.4.2 Global Montelukast Sodium Tablets Sales 2018-2029
1.4.3 Global Montelukast Sodium Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Montelukast Sodium Tablets Market Competition by Manufacturers
2.1 Global Montelukast Sodium Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Montelukast Sodium Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Montelukast Sodium Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Montelukast Sodium Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Montelukast Sodium Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Montelukast Sodium Tablets, Product Type & Application
2.7 Montelukast Sodium Tablets Market Competitive Situation and Trends
2.7.1 Montelukast Sodium Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Montelukast Sodium Tablets Players Market Share by Revenue
2.7.3 Global Montelukast Sodium Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Montelukast Sodium Tablets Retrospective Market Scenario by Region
3.1 Global Montelukast Sodium Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Montelukast Sodium Tablets Global Montelukast Sodium Tablets Sales by Region: 2018-2029
3.2.1 Global Montelukast Sodium Tablets Sales by Region: 2018-2023
3.2.2 Global Montelukast Sodium Tablets Sales by Region: 2024-2029
3.3 Global Montelukast Sodium Tablets Global Montelukast Sodium Tablets Revenue by Region: 2018-2029
3.3.1 Global Montelukast Sodium Tablets Revenue by Region: 2018-2023
3.3.2 Global Montelukast Sodium Tablets Revenue by Region: 2024-2029
3.4 North America Montelukast Sodium Tablets Market Facts & Figures by Country
3.4.1 North America Montelukast Sodium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Montelukast Sodium Tablets Sales by Country (2018-2029)
3.4.3 North America Montelukast Sodium Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Montelukast Sodium Tablets Market Facts & Figures by Country
3.5.1 Europe Montelukast Sodium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Montelukast Sodium Tablets Sales by Country (2018-2029)
3.5.3 Europe Montelukast Sodium Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Montelukast Sodium Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Montelukast Sodium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Montelukast Sodium Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Montelukast Sodium Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Montelukast Sodium Tablets Market Facts & Figures by Country
3.7.1 Latin America Montelukast Sodium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Montelukast Sodium Tablets Sales by Country (2018-2029)
3.7.3 Latin America Montelukast Sodium Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Montelukast Sodium Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Montelukast Sodium Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Montelukast Sodium Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Montelukast Sodium Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Montelukast Sodium Tablets Sales by Type (2018-2029)
4.1.1 Global Montelukast Sodium Tablets Sales by Type (2018-2023)
4.1.2 Global Montelukast Sodium Tablets Sales by Type (2024-2029)
4.1.3 Global Montelukast Sodium Tablets Sales Market Share by Type (2018-2029)
4.2 Global Montelukast Sodium Tablets Revenue by Type (2018-2029)
4.2.1 Global Montelukast Sodium Tablets Revenue by Type (2018-2023)
4.2.2 Global Montelukast Sodium Tablets Revenue by Type (2024-2029)
4.2.3 Global Montelukast Sodium Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Montelukast Sodium Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Montelukast Sodium Tablets Sales by Application (2018-2029)
5.1.1 Global Montelukast Sodium Tablets Sales by Application (2018-2023)
5.1.2 Global Montelukast Sodium Tablets Sales by Application (2024-2029)
5.1.3 Global Montelukast Sodium Tablets Sales Market Share by Application (2018-2029)
5.2 Global Montelukast Sodium Tablets Revenue by Application (2018-2029)
5.2.1 Global Montelukast Sodium Tablets Revenue by Application (2018-2023)
5.2.2 Global Montelukast Sodium Tablets Revenue by Application (2024-2029)
5.2.3 Global Montelukast Sodium Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Montelukast Sodium Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Disha
6.1.1 Disha Corporation Information
6.1.2 Disha Description and Business Overview
6.1.3 Disha Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Disha Montelukast Sodium Tablets Product Portfolio
6.1.5 Disha Recent Developments/Updates
6.2 Green Pine
6.2.1 Green Pine Corporation Information
6.2.2 Green Pine Description and Business Overview
6.2.3 Green Pine Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Green Pine Montelukast Sodium Tablets Product Portfolio
6.2.5 Green Pine Recent Developments/Updates
6.3 Lunan
6.3.1 Lunan Corporation Information
6.3.2 Lunan Description and Business Overview
6.3.3 Lunan Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lunan Montelukast Sodium Tablets Product Portfolio
6.3.5 Lunan Recent Developments/Updates
6.4 Tianyu Pharmaceutical
6.4.1 Tianyu Pharmaceutical Corporation Information
6.4.2 Tianyu Pharmaceutical Description and Business Overview
6.4.3 Tianyu Pharmaceutical Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tianyu Pharmaceutical Montelukast Sodium Tablets Product Portfolio
6.4.5 Tianyu Pharmaceutical Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Corporation Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Otsuka Pharmaceutical Montelukast Sodium Tablets Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 Unimark Remedies
6.6.1 Unimark Remedies Corporation Information
6.6.2 Unimark Remedies Description and Business Overview
6.6.3 Unimark Remedies Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Unimark Remedies Montelukast Sodium Tablets Product Portfolio
6.6.5 Unimark Remedies Recent Developments/Updates
6.7 Hanmi Fine Chemical
6.6.1 Hanmi Fine Chemical Corporation Information
6.6.2 Hanmi Fine Chemical Description and Business Overview
6.6.3 Hanmi Fine Chemical Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hanmi Fine Chemical Montelukast Sodium Tablets Product Portfolio
6.7.5 Hanmi Fine Chemical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Qilu Pharmaceutical Montelukast Sodium Tablets Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Apocalypse Pharma
6.9.1 Apocalypse Pharma Corporation Information
6.9.2 Apocalypse Pharma Description and Business Overview
6.9.3 Apocalypse Pharma Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Apocalypse Pharma Montelukast Sodium Tablets Product Portfolio
6.9.5 Apocalypse Pharma Recent Developments/Updates
6.10 Amicogen
6.10.1 Amicogen Corporation Information
6.10.2 Amicogen Description and Business Overview
6.10.3 Amicogen Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Amicogen Montelukast Sodium Tablets Product Portfolio
6.10.5 Amicogen Recent Developments/Updates
6.11 Hyey
6.11.1 Hyey Corporation Information
6.11.2 Hyey Montelukast Sodium Tablets Description and Business Overview
6.11.3 Hyey Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hyey Montelukast Sodium Tablets Product Portfolio
6.11.5 Hyey Recent Developments/Updates
6.12 Chem Partner
6.12.1 Chem Partner Corporation Information
6.12.2 Chem Partner Montelukast Sodium Tablets Description and Business Overview
6.12.3 Chem Partner Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Chem Partner Montelukast Sodium Tablets Product Portfolio
6.12.5 Chem Partner Recent Developments/Updates
6.13 sinopharm
6.13.1 sinopharm Corporation Information
6.13.2 sinopharm Montelukast Sodium Tablets Description and Business Overview
6.13.3 sinopharm Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 sinopharm Montelukast Sodium Tablets Product Portfolio
6.13.5 sinopharm Recent Developments/Updates
6.14 Curivo
6.14.1 Curivo Corporation Information
6.14.2 Curivo Montelukast Sodium Tablets Description and Business Overview
6.14.3 Curivo Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Curivo Montelukast Sodium Tablets Product Portfolio
6.14.5 Curivo Recent Developments/Updates
6.15 Divine Savior
6.15.1 Divine Savior Corporation Information
6.15.2 Divine Savior Montelukast Sodium Tablets Description and Business Overview
6.15.3 Divine Savior Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Divine Savior Montelukast Sodium Tablets Product Portfolio
6.15.5 Divine Savior Recent Developments/Updates
6.16 MSD
6.16.1 MSD Corporation Information
6.16.2 MSD Montelukast Sodium Tablets Description and Business Overview
6.16.3 MSD Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 MSD Montelukast Sodium Tablets Product Portfolio
6.16.5 MSD Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Montelukast Sodium Tablets Description and Business Overview
6.17.3 Pfizer Montelukast Sodium Tablets Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Pfizer Montelukast Sodium Tablets Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Montelukast Sodium Tablets Industry Chain Analysis
7.2 Montelukast Sodium Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Montelukast Sodium Tablets Production Mode & Process
7.4 Montelukast Sodium Tablets Sales and Marketing
7.4.1 Montelukast Sodium Tablets Sales Channels
7.4.2 Montelukast Sodium Tablets Distributors
7.5 Montelukast Sodium Tablets Customers
8 Montelukast Sodium Tablets Market Dynamics
8.1 Montelukast Sodium Tablets Industry Trends
8.2 Montelukast Sodium Tablets Market Drivers
8.3 Montelukast Sodium Tablets Market Challenges
8.4 Montelukast Sodium Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
